Hollow-Fiber Bioreactors Market Report 2026

Hollow-Fiber Bioreactors Market Overview

• Hollow-Fiber Bioreactors market size has reached to $1.5 billion in 2025 • Expected to grow to $2.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Rising Demand For Cell-Based Therapy Production Is Fueling The Growth Of Market Due To Growing Focus On Scalable And High-Yield Manufacturing Solutions • Market Trend: Innovative Hollow-Fiber Bioreactors Driving Growth In Cell Therapy And ATMP Manufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hollow-Fiber Bioreactors Market?

Hollow-fiber bioreactors are advanced cell culture systems that use bundles of semi-permeable hollow fibers to create a high surface area environment for cell growth and product production. These bioreactors enable efficient exchange of nutrients, gases, and waste, closely mimicking physiological conditions. They are commonly used for high-density cell culture, protein production, and continuous perfusion processes in biomanufacturing and research applications. The main product types of hollow-fiber bioreactors include single-use hollow-fiber bioreactors and reusable hollow-fiber bioreactors. Single-use hollow-fiber bioreactors are systems designed for one-time use, incorporating pre-sterilized components that reduce the need for extensive cleaning and preparation between production runs. It is applied for cell culture, tissue engineering, biopharmaceutical production, wastewater treatment, and others by several end-users, including pharmaceutical and biotechnology companies, research institutes, contract research organizations, and others.

What Is The Hollow-Fiber Bioreactors Market Growth Forecast?

The hollow-fiber bioreactors market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to technological advancements in single-use bioreactors, expansion of modular and automated systems, rising demand for high-throughput protein production, increasing contract research organization (CRO) outsourcing, integration with continuous perfusion and monitoring systems. Major trends in the forecast period include increasing adoption of single-use hollow-fiber bioreactors, growth in high-density cell culture applications, rising demand for biopharmaceutical protein production, expansion of tissue engineering and regenerative medicine, focus on automated and high-throughput bioreactor systems.

Global Hollow-Fiber Bioreactors Market Segmentation

1) By Product Type: Single-Use Hollow-Fiber Bioreactors, Reusable Hollow-Fiber Bioreactors 2) By Application: Cell Culture, Tissue Engineering, Biopharmaceutical Production, Wastewater Treatment, Other Applications 3) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Contract Research Organizations, Other End-Users Subsegments: 1) By Single-Use Hollow-Fiber Bioreactors: Pre-Assembled Single-Use Hollow-Fiber Bioreactors, Modular Single-Use Hollow-Fiber Bioreactors, Customizable Single-Use Hollow-Fiber Bioreactors, High-Throughput Single-Use Hollow-Fiber Bioreactors, Automated Single-Use Hollow-Fiber Bioreactors 2) By Reusable Hollow-Fiber Bioreactors: Fixed-Bed Reusable Hollow-Fiber Bioreactors, Modular Reusable Hollow-Fiber Bioreactors, High-Capacity Reusable Hollow-Fiber Bioreactors, Multipurpose Reusable Hollow-Fiber Bioreactors, Clean-In-Place Reusable Hollow-Fiber Bioreactors

What Are The Drivers Of The Hollow-Fiber Bioreactors Market?

The rising demand for cell-based therapy production is expected to propel the growth of the hollow-fiber bioreactors market going forward. Cell-based therapy production refers to the process of manufacturing therapeutic products derived from living cells to treat or manage various diseases, including cancers, autoimmune disorders, and genetic conditions. The demand for cell-based therapy production is increasing due to the growing need for scalable and consistent manufacturing platforms that can support high cell densities without compromising product quality. Hollow-fiber bioreactors support cell-based therapy production by offering a closed, high-surface-area system that enables efficient expansion and harvesting of therapeutic cells under controlled conditions. For instance, in December 2024, according to the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, six first-in-class cell and gene treatments were introduced in 2023, which is 50% more than the three that were introduced in 2022. Therefore, the rising demand for cell-based therapy production is driving the growth of the hollow-fiber bioreactors industry. The increasing prevalence of personalized medicine is expected to propel the growth of the hollow-fiber bioreactors market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare decisions to the individual characteristics, needs, and genetic profile of each patient. The rise of personalized medicine is due to the rising adoption of advanced diagnostic technologies that can precisely identify patient-specific disease mechanisms as healthcare providers aim to improve treatment outcomes and reduce trial-and-error in therapy selection. Hollow-fiber bioreactors support personalized medicine by enabling scalable, high-quality cell culture production that facilitates the development of patient-specific therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing prevalence of personalized medicine is driving the growth of the hollow-fiber bioreactors industry.

Key Players In The Global Hollow-Fiber Bioreactors Market

Major companies operating in the hollow-fiber bioreactors market are General Electric Company, Veolia Environnement S.A., Thermo Fisher Scientific Inc., Mitsubishi Chemical Corporation, Kubota Corporation, DuPont de Nemours Inc., MANN+HUMMEL GmbH, Alfa Laval AB, Sartorius AG, Repligen Corporation, Shenzhen Dreamemway Environmental Products Co. Ltd., FiberCell Systems Inc., Reynolds Culligan Water, Shanghai MegaVision Membrane Engineering & Technology Co. Ltd., Memfill Tech Private Limited, FibraCast Inc., iMemFlo Membrane Technology Co. Ltd., Guangdong Skyview Environmental Science and Technology Co. Ltd., PHILOS Co. Ltd., Blufox Engineering Pvt. Ltd.

Global Hollow-Fiber Bioreactors Market Trends and Insights

Major companies operating in the hollow-fiber bioreactors market are focusing on developing innovative solutions, such as single-use hollow-fiber membrane networks to enable high-density, scalable, and low-shear cell culture for advanced therapies. Single-use hollow-fiber membrane networks are disposable bioreactor systems composed of semi-permeable fibers that allow continuous nutrient delivery and waste removal, helping maintain uniform nutrient distribution, low-shear conditions, and scalable high-density cell growth while reducing contamination risk and simplifying biomanufacturing. For instance, in March 2025, ABEC Inc., a US-based process‑engineering company, launched its ATB (Advanced Therapy Bioreactor) a single-use, closed, hollow-fiber bioreactor platform designed specifically for advanced therapy medicinal product (ATMP) manufacturing. The ATB system features proprietary hollow-fibre membrane networks that mimic the human circulatory system to deliver localised nutrient and gas exchange, combined with oscillation-based mixing instead of mechanical agitation to maintain optimal growth environments. Its design supports consistent scale‑up from 0.2 L to 10 L, preserving the same hollow-fibre surface-area-to-volume ratio across scales, and has demonstrated high densities and viabilities for a range of difficult-to-culture cells, including primary T-cells, CD34+ stem cells, HEK293, and CHO lines.

Regional Outlook

North America was the largest region in the hollow-fiber bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hollow-Fiber Bioreactors Market?

The hollow-fiber bioreactors market consists of sales of membrane-based hollow-fiber bioreactors, perfusion hollow-fiber bioreactors, high-density hollow-fiber bioreactors, oxygen-permeable hollow-fiber bioreactors, and modular hollow-fiber bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.